Viewing Study NCT05301569


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-25 @ 8:27 PM
Study NCT ID: NCT05301569
Status: RECRUITING
Last Update Posted: 2023-12-05
First Post: 2022-03-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Relation Between Serum IGF-1 & BMI In Acne Vulgaris
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'CROSS_SECTIONAL', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 90}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-04-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-12', 'completionDateStruct': {'date': '2024-05-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-12-03', 'studyFirstSubmitDate': '2022-03-16', 'studyFirstSubmitQcDate': '2022-03-26', 'lastUpdatePostDateStruct': {'date': '2023-12-05', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2022-03-29', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-05-30', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Evaluation of serum level of insulin like growth factor 1 in acne vulgaris', 'timeFrame': '1 year', 'description': 'using the Chemiluminescent Microparticle Immunoassay'}]}, 'conditionsModule': {'conditions': ['Evaluation of Serum Level of Insulin Like Growth Factor 1']}, 'descriptionModule': {'briefSummary': 'cross-sectional study in which participants will be recruited at dermatology \\& Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists \\& obtaining an informed consent'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT'], 'maximumAge': '45 Years', 'minimumAge': '15 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Acne vulgaris patients aged from 15 to 45 years old', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Patients aged from 15 to 45 years old suffering from acne vulgaris.\n2. Both sexes.\n\nExclusion Criteria:\n\n1. Insulin resistance and diabetic patients\n2. Females with polycystic ovarian syndrome\n3. Treatment with drugs that can influence IGF-1level such as corticosteroid, insulin, hypoglycemic agents, and isotretinoin within one year before the date of study.\n4. Other causes of acne or acneform eruption as steroid-induced'}, 'identificationModule': {'nctId': 'NCT05301569', 'briefTitle': 'Relation Between Serum IGF-1 & BMI In Acne Vulgaris', 'organization': {'class': 'OTHER', 'fullName': 'Assiut University'}, 'officialTitle': 'Relation Between Serum Insulin Like Growth Factor 1 and Body Mass Index in Acne Vulgaris', 'orgStudyIdInfo': {'id': 'IGF-1 in AV'}}, 'contactsLocationsModule': {'locations': [{'zip': '13772', 'city': 'Cairo', 'state': 'Qalubya', 'status': 'RECRUITING', 'country': 'Egypt', 'contacts': [{'name': 'Rania Sallam', 'role': 'CONTACT', 'email': 'Raniamohamed0887@gmail.com', 'phone': '113567939'}], 'facility': 'Rania Sallam', 'geoPoint': {'lat': 30.06263, 'lon': 31.24967}}], 'centralContacts': [{'name': 'Rania Sallam', 'role': 'CONTACT', 'email': 'Raniamohamed0887@gmail.com', 'phone': '113567939'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Assiut University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal investigator', 'investigatorFullName': 'Rania Sallam Mohamed Taha', 'investigatorAffiliation': 'Assiut University'}}}}